HIV-1 Gene Suppression by CD8+ T Cells
HIV-1 Gene Suppression by CD8+ T Cells
批准号:
7574498
负责人:
GEORGIA Doris TOMARAS
金额:
$31.2万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2011-03-31
关键词:
AffectAnti-Retroviral AgentsAntiviral AgentsAntiviral ResponseBiological AssayCD8-Positive T-LymphocytesCD8B1 geneCellsChimera organismChromatin StructureCoculture TechniquesDataDiseaseEpigenetic ProcessEvaluationEventGene ExpressionGenesGenetic TranscriptionGenomeGoalsHIVHIV InfectionsHIV vaccineHIV-1Histone DeacetylaseHumanImmune responseIn VitroInfection preventionLaboratoriesLengthLinkMapsMediatingMolecularMolecular CloningMutationNuclear ExtractOutcomeOutcome StudyPathway interactionsPatientsPhenotypePlayProvirusesRNA SplicingRegulationRepressionResistanceResourcesRoleSP1 geneSite-Directed MutagenesisT-LymphocyteTestingTherapeutic InterventionTimeTransactivationTranscription InitiationTranscriptional RegulationTreatment ProtocolsUp-RegulationVaccinationVaccine DesignVaccinesViralViremiaVirusVirus LatencyVirus ReplicationWorkabstractingautologous lymphocytesbasec-myc Geneschromatin remodelingcis acting elementdesigngene repressiongenetic elementin vivonovelprotein expressiontat Proteinvaccination strategyvaccine candidateviral resistancevirus genetics
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Elimination of HIV replication in vivo has not been achieved to date because HIV establishes and persists in a latent state in host cells. Although attempts have been made to activate and eliminate these reservoirs, the most potent antiretroviral regimens in use today do not eradicate HIV from its latent state. For HIV, it is not known how provirus latency is induced and maintained in vivo. A better understanding of whether host immune responses are involved in HIV latency is needed. We have determined that noncytolytic CD8 suppression occurs during the time of virus gene expression and inhibits the initiation of virus transcription. We now have evidence that the same epigenetic changes that occur during provirus latency also occur as a result of noncytolytic CD8 suppression. We propose to build upon this novel finding to determine if noncytolytic CD8 suppression is directly involved in HIV latency. The molecular events of chromatin remodeling required for transcriptional regulation will be examined to determine the linkage between noncytolytic CD8 suppression and provirus latency. Analyses of chimeras of genetically related pair of viruses with opposing sensitivities to CD8 suppression will determine if the resistant virus phenotype results from molecular changes required for latency. The results from this study can provide a better understanding of the current limitations of antiretrovirals, in addition to immediately altering candidate HIV vaccine design and evaluation. Potential implications of this work are that noncytolytic CD8 T cells would be of benefit for disease-modifying vaccine strategies aimed to reduce peak viremia and set point, but would not be of benefit for preventative vaccine strategies. This study has two specific aims: 1. Determine if noncytolytic CD8+ T cell mediated HIV suppression causes HIV latency. 2. Identify the viral genetic changes linked to noncytolytic CD8 resistance and determine the role of latency.
PUBLIC HEALTH RELEVANCE: Noncytolytic CD8 T cell mediated suppression plays an important role in viral control in natural HIV infection and thus could be an important immune response to elicit by vaccination. Conversely, the elicitation of this immune response may be undesirable if a protective vaccination strategy is the goal. The results from this study will determine if induction of noncytolytic CD8 T cells would be beneficial in a protective vaccination strategy or whether it should be restricted to disease-modifying vaccine strategies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
-
批准号:10258146
-
项目类别:
-
资助金额:$434.33万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Mechanisms of Antibody Fc Mediated Protection
-
批准号:10475284
-
项目类别:
-
资助金额:$59.14万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Administrative Core
-
批准号:10670243
-
项目类别:
-
资助金额:$25.9万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Antiviral Activity In Situ
-
批准号:10475294
-
项目类别:
-
资助金额:$85.28万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
-
批准号:10670229
-
项目类别:
-
资助金额:$444.84万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Administrative Core
-
批准号:10258147
-
项目类别:
-
资助金额:$33.21万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Impact of Antibody Effector Function Diversity on Antiviral Activity In Situ
-
批准号:10475274
-
项目类别:
-
资助金额:$426.07万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Antiviral Activity In Situ
-
批准号:10670262
-
项目类别:
-
资助金额:$59.14万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Mechanisms of Antibody Fc Mediated Protection
-
批准号:10258150
-
项目类别:
-
资助金额:$60.67万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Structure-Function Analytics Core
-
批准号:10670249
-
项目类别:
-
资助金额:$100.92万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Structure-Function Analytics Core
-
批准号:10258149
-
项目类别:
-
资助金额:$76.49万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Mechanisms of Antibody Fc Mediated Protection
-
批准号:10670254
-
项目类别:
-
资助金额:$85.63万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Structure-Function Analytics Core
-
批准号:10475280
-
项目类别:
-
资助金额:$73.44万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Administrative Core
-
批准号:10475275
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Antiviral Activity In Situ
-
批准号:10258152
-
项目类别:
-
资助金额:$100.02万
-
财政年份:2021
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
-
批准号:9925737
-
项目类别:
-
资助金额:$410.48万
-
财政年份:2016
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Administrative Core
-
批准号:9140248
-
项目类别:
-
资助金额:$14.72万
-
财政年份:2016
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Bridging Antibody Fc-mediated Antiviral Functions Across Humans and Non-human Primates
-
批准号:9140247
-
项目类别:
-
资助金额:$326.41万
-
财政年份:2016
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Centers for AIDS Research (CFAR)
-
批准号:10163778
-
项目类别:
-
资助金额:$330.19万
-
财政年份:2005
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
Immunology Core (Basic Science Core)
-
批准号:10673776
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2005
-
负责人:GEORGIA Doris TOMARAS
-
依托单位:
海外基金